Expert Perspectives on Diagnosis and Treatment of Irritable Bowel Syndrome

What can we help you find?
Following their discussion of available agents for irritable bowel syndrome with constipation (IBS-C), the panel considers how to optimally stratify patients.
Experts break down the appropriate use of guanylate cyclase-C agonists for irritable bowel syndrome with constipation (IBS-C).
Switching their focus to irritable bowel syndrome with constipation (IBS-C), panelists evaluate the use of laxatives and lubiprostone, respectively.
In the setting of irritable bowel syndrome with diarrhea (IBS-D), key opinion leaders reflect on the role of eluxadoline.
A panel of experts provide their perspective on the use of rifaximin to manage patients with irritable bowel syndrome with diarrhea (IBS-D).
An overview of 5-HT3 directed therapy’s role in treating irritable bowel syndrome with diarrhea (IBS-D).
Experts consider the role of antispasmodics and neuromodulators in managing patients with irritable bowel syndrome (IBS).
Panelists share a brief discussion on the potential role of fecal microbiota transplantation (FMT) in irritable bowel syndrome (IBS).
Starting their conversation on therapeutic options for irritable bowel syndrome [IBS], key opinion leaders consider diet’s role in management.
Following a discussion on the differential diagnosis of irritable bowel syndrome [IBS], experts consider how identification methods are becoming more accurate.
Panelists share insight on what is included in a diagnostic work-up of irritable bowel syndrome (IBS).
A comprehensive review of an irritable bowel syndrome (IBS) diagnosis, including the various subtypes of disease.
+ Load More